Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FXJA4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,904
Award facts
- Contract value 100% obligated
- $10,904.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Wegovy 2.4 mg/0.75 mL pens with a ceiling value of $10,904.15. This is a firm fixed-price delivery order with an ultimate completion date of May 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, indicating it was awarded through open competition. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors, maintains extensive federal contracting relationships with the Defense Logistics Agency and related military healthcare systems. The company supplies a broad portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. Wegovy, a medication used in weight management treatments, represents part of the company's diverse pharmaceutical offerings that include diabetes medications, neurological treatments, and specialized medical commodities. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its established capability to meet federal medical procurement requirements and support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FXJA4?
SPE2DB25FXJA4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 27, 2025.
How much is contract SPE2DB25FXJA4 worth?
The government has obligated $10,904 on SPE2DB25FXJA4.
Is contract SPE2DB25FXJA4 an order under another contract?
Yes. SPE2DB25FXJA4 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXJA4 competed?
The extent of competition for SPE2DB25FXJA4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award